Pre-surgery exercise and care program for limb sarcoma
Part of Bones, joints & muscles, Cancer clinical trials.
This Phase 2 trial tests a “prehabilitation” program done before surgery to help people with arm or leg (limb) sarcoma be better prepared for their operation. It may help improve how well patients tolerate treatment and recover by planning supportive care around the weeks before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 or older
- Have confirmed bone or soft-tissue sarcoma (tumor in an arm or leg)
- Your cancer plan includes treatment before surgery (radiation and/or chemotherapy)
- Join before surgery starts, and have surgery scheduled about 6–10 weeks after joining
- If cancer has spread, the main tumor in the arm/leg must have optimal surgery planned
- Be able to follow study visits and procedures; agree in writing (and provide minor assent if under 18)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This trial tests a special care plan before, during, and after surgery to lower the risk of problems for people with sarcoma. It compares this new approach to standard care for 300 patients.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This trial tests whether giving stronger chemotherapy before and/or after surgery helps people with high-risk, resectable soft-tissue sarcoma. It aims to lower the chance the cancer comes back by improving treatment around the time of the operation.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.